Breast Imaging Practice Questions

Q: What is the characteristic pattern of a lesion showing progressive enhancement on Breast MRI?

Type I curve. In Breast MRI, the **Kinetic Curve Analysis** (Time-Intensity Curve) describes how contrast moves into and out of a lesion. This is a high-yield topic for NEET-PG. ### **Explanation of the Correct Answer** * **Type I Curve (Persistent/Progressive Enhancement):** This curve shows a steady, continuous increase in signal intensity over time without a plateau. It indicates that the contrast continues to accumulate in the interstitial space. * **Clinical Significance:** This pattern is typically associated with **benign lesions** (e.g., fibroadenomas or areas of fibrocystic change). The probability of malignancy for a Type I curve is low (~5-10%). ### **Analysis of Incorrect Options** * **Type II Curve (Plateau Pattern):** The signal intensity increases initially but then levels off (plateaus) in the delayed phase. This is an intermediate/suspicious finding, with a malignancy risk of ~30-40%. * **Type III Curve (Washout Pattern):** The signal intensity increases rapidly but then drops significantly (washes out) in the delayed phase. This is highly suggestive of **malignancy** (~85-90% risk) due to neoangiogenesis and leaky vessels in tumors. * **Type IV Curve:** This is a distractor; there is no "Type IV" curve in the standard BI-RADS kinetic assessment. ### **High-Yield Clinical Pearls for NEET-PG** * **Gold Standard:** MRI is the most sensitive modality for detecting breast cancer (Sensitivity >90%). * **Indications:** Screening high-risk patients (BRCA mutations), assessing implant rupture, and evaluating occult primary breast cancer. * **BI-RADS Lexicon:** Kinetic analysis consists of two phases: the **Initial phase** (first 2 mins) and the **Delayed phase** (after 2 mins or when the curve changes). * **Mnemonic:** **P**ersistent = **P**robably Benign (Type I); **W**ashout = **W**orrisome (Type III).

Q: Mammography is useful in what scenario?

All of the above. ### Explanation Mammography remains the gold standard for breast cancer screening due to its high sensitivity in specific clinical scenarios. The correct answer is **All of the above** because: 1. **Detection of Early Cancers:** Mammography is the only screening tool proven to reduce mortality by detecting non-palpable, asymptomatic cancers. Its hallmark is the identification of **grouped pleomorphic microcalcifications**, which are often the earliest sign of Ductal Carcinoma in Situ (DCIS). 2. **Lobular Carcinoma of the Opposite Breast:** Invasive Lobular Carcinoma (ILC) is notorious for being **multicentric and bilateral** (up to 10-15% of cases). When a malignancy is detected in one breast, a bilateral mammogram is mandatory to rule out synchronous lesions in the contralateral breast. 3. **Large Fatty Breasts:** Mammography is most effective in older women with "fatty replacement" of breast tissue (ACR Category A or B density). Fat appears **radiolucent (black)**, providing an excellent natural contrast against which **radiopaque (white)** masses or spiculae are easily visualized. **Why other options are inclusive:** While mammography has limitations in dense (younger) breasts, it is universally indicated for the scenarios mentioned above to ensure comprehensive staging and early intervention. ### Clinical Pearls for NEET-PG: * **Standard Views:** Craniocaudal (CC) and Mediolateral Oblique (MLO). The MLO view visualizes the maximum amount of breast tissue, including the **axillary tail of Spence**. * **BI-RADS Scoring:** A score of **0** means incomplete (needs further imaging); **3** is probably benign (short-interval follow-up); **4/5** requires biopsy. * **Best Time for Mammography:** Day 7–10 of the menstrual cycle (to minimize tenderness and engorgement). * **Screening Age:** Usually starts at **40 years** (as per ACR/ACS guidelines). For high-risk patients, MRI is the preferred adjunct.

Q: Mammography is not advised in which of the following groups?

All of the above. **Explanation:** Mammography is generally avoided in the groups mentioned due to physiological factors that compromise image quality and safety concerns regarding ionizing radiation. 1. **Adolescent age group:** In young females, the breast tissue is **physiologically dense** (high ratio of glandular tissue to fat). On a mammogram, both dense tissue and tumors appear white (radio-opaque), leading to poor sensitivity and a high false-negative rate. Furthermore, young breast tissue is highly sensitive to ionizing radiation. **Ultrasound (USG)** is the primary imaging modality for patients under 30–35 years. 2. **Pregnant females:** While the radiation dose to the fetus is minimal with shielding, the breast undergoes gestational changes (increased vascularity and glandular proliferation), making the tissue extremely dense and difficult to interpret. USG is the preferred safe alternative. 3. **Mastitis:** In acute inflammatory conditions, the breast is tender, making the compression required for mammography extremely painful. Additionally, inflammation increases tissue density and skin thickening, which can mimic or mask underlying malignancy. **Clinical Pearls for NEET-PG:** * **Gold Standard Screening:** Mammography is the gold standard for breast cancer screening in women >40 years. * **Best Time for Mammogram:** Day 7 to 10 of the menstrual cycle (when breasts are least tender and dense). * **BI-RADS:** The Breast Imaging-Reporting and Data System is used for standardized reporting. * **Microcalcifications:** These are the earliest sign of ductal carcinoma in situ (DCIS) visible on mammography. * **MRI Breast:** Indicated for high-risk screening (e.g., BRCA mutations) or evaluating implant rupture.

Q: What is the investigation of choice for a female with high risk of breast cancer?

MRI. **Explanation:** **MRI (Magnetic Resonance Imaging)** is the investigation of choice for screening females at high risk for breast cancer (e.g., BRCA1/BRCA2 mutation carriers, first-degree relatives of BRCA carriers, or those with a >20-25% lifetime risk). The primary reason is its **superior sensitivity** (approaching 90-100%) compared to mammography, especially in younger women who often have dense breast tissue. MRI can detect small, invasive cancers that are occult on other imaging modalities. **Analysis of Incorrect Options:** * **Mammography:** While it is the gold standard for screening the **general population** (average risk), it has lower sensitivity in high-risk women, who often develop "interval cancers" that mammography misses due to dense parenchyma. * **USG (Ultrasonography):** This is the investigation of choice for **young symptomatic women (<30 years)** and for differentiating cystic from solid masses. It is an adjunct to mammography but not a standalone screening tool for high-risk patients. * **Clinical Examination:** While essential, it cannot detect non-palpable early-stage malignancies, which is the goal of high-risk screening. **High-Yield Clinical Pearls for NEET-PG:** * **Screening Protocol:** In high-risk patients, annual Contrast-Enhanced MRI is recommended, usually starting at age 25–30. * **BI-RADS:** The Breast Imaging-Reporting and Data System is used to standardize reporting. BI-RADS 0 requires further imaging; BI-RADS 6 is biopsy-proven malignancy. * **IOC for Breast Implant Rupture:** MRI is the investigation of choice. * **Most Specific Sign of Malignancy on Mammography:** Spiculated mass or pleomorphic microcalcifications.

Q: A 35-year-old lactating mother presented with a painful breast lump. Which is the first investigation to be done?

USG. **Explanation:** The correct answer is **USG (Ultrasonography)**. In a young, lactating mother presenting with a painful breast lump, the primary clinical suspicion is a **lactational abscess** or **galactocele**. **Why USG is the investigation of choice:** 1. **Dense Breast Tissue:** Young and lactating women have high glandular breast density, which makes mammography less sensitive as it can mask underlying lesions ("white on white" effect). 2. **Safety:** USG involves no ionizing radiation, making it safe for both the mother and the nursing infant. 3. **Diagnostic Utility:** USG is superior at differentiating between solid masses and fluid-filled collections (abscesses/cysts). It also allows for immediate ultrasound-guided needle aspiration for both diagnosis and therapy. **Why other options are incorrect:** * **Mammography:** This is the gold standard for screening in women >40 years. In younger/lactating women, it is avoided as the first-line due to decreased sensitivity and radiation exposure. * **MRI:** While highly sensitive, MRI is expensive, not readily available, and usually reserved for high-risk screening or characterization of complex cases where USG/Mammography are inconclusive. * **X-ray:** Conventional X-ray has no role in breast imaging; Mammography is the specific low-dose X-ray technique used for breasts. **High-Yield Clinical Pearls for NEET-PG:** * **Investigation of choice for breast lump 40 years:** Mammography. * **BI-RADS (Breast Imaging-Reporting and Data System):** A standardized scoring system used to communicate the risk of malignancy (0-6). * **Snowstorm Appearance on USG:** Classic sign of extracapsular silicone implant rupture. * **Popcorn Calcification on Mammography:** Pathognomonic for an involuting Fibroadenoma.

Q: What does the abbreviation DIBIRADS stand for in the context of breast imaging?

Breast Imaging Reporting and Data System. **Explanation:** The **BI-RADS (Breast Imaging-Reporting and Data System)** is a standardized quality assurance tool developed by the **American College of Radiology (ACR)**. It provides a universal language for reporting breast imaging findings (Mammography, Ultrasound, and MRI), ensuring consistency between radiologists and referring clinicians. **Why Option A is Correct:** The acronym stands for **Breast Imaging Reporting and Data System**. Its primary purpose is to reduce ambiguity in breast imaging reports, provide a standardized assessment of findings, and offer specific management recommendations based on the level of suspicion for malignancy. **Why Other Options are Incorrect:** * **Options B & D:** "Best" is an incorrect descriptor; the system is defined by the anatomical site (Breast), not a qualitative adjective. * **Option C:** While there are other "RADS" systems (like LI-RADS for liver or TI-RADS for thyroid), there is no standard "Brain Imaging Reporting and Data System" under this specific nomenclature. **High-Yield Clinical Pearls for NEET-PG:** * **BI-RADS Categories:** * **0:** Incomplete (needs further imaging). * **1:** Negative (0% risk). * **2:** Benign (0% risk). * **3:** Probably Benign ( 95% risk). * **6:** Known Biopsy-proven malignancy. * **Breast Density:** BI-RADS also classifies breast density (A to D), which is crucial because high density can mask small tumors on mammography. * **Management:** BI-RADS 4 and 5 always necessitate tissue diagnosis (biopsy).

Q: When is mammography optimally performed in relation to the menstrual cycle?

During the first half of the menstrual cycle. **Explanation:** **1. Why Option A is Correct:** Mammography is optimally performed during the **first half of the menstrual cycle (Follicular Phase)**, typically between days 5 and 12. During this phase, levels of estrogen and progesterone are relatively low. In the second half (Luteal Phase), increased progesterone causes physiological changes including breast engorgement, increased water content (edema), and increased glandular density. Performing the scan in the first half ensures **minimal breast tenderness** (improving patient cooperation for compression) and **lower parenchymal density**, which enhances the diagnostic sensitivity for detecting small masses or microcalcifications. **2. Why Other Options are Incorrect:** * **Option B:** During the second half of the cycle, the breasts are often tender and swollen. The increased density can "mask" underlying lesions (the "silhouette effect"), leading to higher recall rates or false negatives. * **Options C & D:** While these days fall within the first half, they are too specific. While the 5th day is often cited as the *start* of the ideal window, the entire first half (pre-ovulatory) is generally acceptable. Option A is the more comprehensive and standard clinical recommendation. **3. Clinical Pearls for NEET-PG:** * **BI-RADS:** Remember the Breast Imaging-Reporting and Data System (0-6). BI-RADS 3 (Probably Benign) requires a 6-month follow-up. * **Young Patients:** In women <35 years, **Ultrasound** is the initial investigation of choice due to high breast density and radiation sensitivity. * **Screening:** Standard screening mammography involves two views: **Craniocaudal (CC)** and **Mediolateral Oblique (MLO)**. * **Calcifications:** Fine, pleomorphic, or linear branching calcifications are highly suspicious for malignancy (DCIS).

Q: What is the hallmark of breast malignancy on mammography?

Clusters of microcalcification. **Explanation:** The hallmark of breast malignancy on mammography is the presence of **clusters of pleomorphic microcalcifications**. These are typically small (<0.5 mm), irregular in shape, and vary in size and density. They represent calcium deposits within necrotic debris or secretions in the ducts (as seen in DCIS) or the stroma of an invasive tumor. While a spiculated mass is the most specific sign of malignancy, microcalcifications are often the earliest and most common mammographic sign of non-palpable cancers. **Analysis of Options:** * **A. Low density lesion:** Malignant lesions are typically **high-density** (radiopaque) compared to the surrounding fibroglandular tissue due to increased cellularity and stromal reaction (desmoplasia). * **B. Smooth margins:** Smooth, well-circumscribed margins are characteristic of **benign** lesions (e.g., simple cysts or fibroadenomas). Malignant lesions typically exhibit **spiculated, microlobulated, or obscured** margins. * **D. Popcorn calcification:** This is a classic "benign" calcification pattern. Large, coarse "popcorn" calcifications are pathognomonic for an **involuting fibroadenoma**. **High-Yield Clinical Pearls for NEET-PG:** * **BI-RADS Classification:** Used for standardized reporting. BI-RADS 4 (Suspicious) and 5 (Highly suggestive of malignancy) require biopsy. * **Most Specific Sign:** A **spiculated mass** is the most specific mammographic feature of malignancy. * **Stellate Lesions:** Differential includes Invasive Ductal Carcinoma (IDC), Radial Scar (benign but mimics cancer), and Fat Necrosis. * **Screening:** Mammography is the gold standard for screening women >40 years. For younger women or those with dense breasts, **Ultrasound (USG)** is the preferred initial modality.

Q: Identify the investigation shown in the image:

Mammography. ***Mammography*** - The image displays the characteristic features of a mammogram, which is a specialized **low-dose X-ray** of the breast used for screening and diagnosis. - It clearly delineates the breast's internal structures, including **glandular tissue**, **adipose tissue**, and **ducts**, which is the primary purpose of this imaging modality. *CT* - A **Computed Tomography (CT)** scan produces cross-sectional (slice) images, whereas the image shown is a projectional view of the entire breast, typical of mammography. - CT scans of the chest would typically show surrounding structures like ribs, lungs, and the sternum, which are absent in this focused view. *X-ray* - While mammography is a type of X-ray, in clinical practice, the term "X-ray" usually refers to a standard radiograph (e.g., chest X-ray) that is not optimized for detailed **soft-tissue differentiation** of the breast. - The technique involves breast compression and specific views (like mediolateral oblique or craniocaudal) that are unique to mammography, not general radiography. *MRI* - **Magnetic Resonance Imaging (MRI)** of the breast produces images with different tissue contrast and appearance, often using gadolinium contrast to assess vascularity. - The texture and resolution of an MRI are distinct, and it does not typically show microcalcifications with the same clarity as a mammogram.

Question 1

What is the characteristic pattern of a lesion showing progressive enhancement on Breast MRI?

Accepted Answer

Type I curve

Answer

Type II curve

Answer

Type III curve

Answer

Type IV curve

Question 2

Mammography is useful in what scenario?

Accepted Answer

All of the above

Answer

Detection of early cancers

Answer

Lobular carcinoma of the opposite breast

Answer

Large fatty breasts

Question 3

Mammography is not advised in which of the following groups?

Accepted Answer

All of the above

Answer

Pregnant females

Answer

Mastitis

Answer

Adolescent age group

Question 4

What is the investigation of choice for a female with high risk of breast cancer?

Accepted Answer

MRI

Answer

USG

Answer

Mammography

Answer

Clinical examination

Question 5

A 35-year-old lactating mother presented with a painful breast lump. Which is the first investigation to be done?

Accepted Answer

USG

Answer

Mammography

Answer

MRI

Answer

X-ray

Question 6

What does the abbreviation DIBIRADS stand for in the context of breast imaging?

Accepted Answer

Breast Imaging Reporting and Data System

Answer

Best Imaging Reporting and Data System

Answer

Brain Imaging Reporting and Data System

Answer

Best imaging Reporting and Data System

Question 7

What is the investigation of choice for a lactating female presenting with a painful breast lump?

Accepted Answer

Ultrasound (USG)

Answer

Computed Tomography (CT)

Answer

Magnetic Resonance Imaging (MRI)

Answer

Mammogram

Question 8

When is mammography optimally performed in relation to the menstrual cycle?

Accepted Answer

During the first half of the menstrual cycle

Answer

During the second half of the menstrual cycle

Answer

On the 3rd day of the menstrual cycle

Answer

On the 5th day of the menstrual cycle

Question 9

What is the hallmark of breast malignancy on mammography?

Accepted Answer

Clusters of microcalcification

Answer

Low density lesion

Answer

Smooth margins

Answer

Popcorn calcification

Question 10

Identify the investigation shown in the image:

Accepted Answer

Mammography

Answer

CT

Answer

X-ray

Answer

MRI

Breast Imaging — MCQs

Breast Imaging — MCQs

On this page

Practice by Chapter

Want unlimited practice?